Both Moderna and Pfizer get the go-ahead.
On Tuesday, the Food and Drug Administration approved Pfizer’s and Moderna’s COVID-19 booster shot for individuals aged 50 and older. The inoculations are designed to work as short-term immunity boosters as the novel virus morphs into new and more contagious variants. The shot is also intended to protect against severe illness. It is unclear how long protection from the booster shot will last.
Providers will be given the okay to begin administering the fourth shot once the Centers for Disease Control and Prevention sign off on the measure. Though multiple kinds of booster shots are now available, the CDC and health practitioners are unsure when the correct window of time to fully utilize them will occur.
Immunocompromised people are already eligible for the fourth shot.
As the Lord Leads, Pray with Us…
- For FDA officials as they assess and evaluate inoculations and therapies for public health.
- For CDC Director Walensky as she oversees her agency’s approvals and issues guidance.
Sources: Just The News, Washington Examiner, AP
